Please login to the form below

Not currently logged in
Email:
Password:

CSCC

This page shows the latest CSCC news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC

NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC

The drug is the first and only systemic treatment option available for CSCC patients in England. ... NICE’s decision was based on positive results from the EMPOWER-CSCC-1 trial.

Latest news

More from news
Approximately 3 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...